Telehealth medication abortion as safe as pills prescribed in-person, study finds

A new study published in Nature Medicine offers additional evidence that abortion pills are safe to prescribe — even remotely.

February 15, 2024 Check out STAT+

Sponsored By

Alex Hogan/STAT Juul's internal playbook opens a rare window into influence in Washington Juul documents provide a rare look at special interest group lobbying: dark money donations, paying think tanks, and buying public comments. By Nicholas Florko Abortion pills offered via telehealth as safe as in-person medication abortions, study finds Study finds no increase in adverse reactions with telehealth abortions. Combination of mifepristone, misoprostol shown to be safe, effective. By Annalisa Merelli Lyme disease cases rise, but largely due to a change in data collection A new CDC report shows Lyme disease cases rose by 69% in 2022 over previous years. It's due to a new way of doing surveillance. By Helen Branswell Sarah Silbiger/Getty Images STAT+ | FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound The FDA is concerned these websites that sell the underlying chemicals in Wegovy and Zepbound are marketing unapproved products to consumers. By Elaine Chen Long Covid research funding at NIH gets a nearly 50% boost The National Institutes of Health gave a project to study and test treatments for long Covid a major cash infusion. By Rachel Cohrs Covid-19 vaccine confidence soured by officials' messaging, Republicans argue A House hearing on vaccine safety claims sought to pierce through Americans' falling confidence in routine shots and the spread of Covid-19 misinformation. By Sarah Owermohle Molly Ferguson/STAT STAT+ | Gaming Amylyx stock reactions to the next ALS drug test, and a chat with CRISPR's CEO about a new investor Adam Feuerstein games out upcoming results on the supplement TUDCA for ALS patients, and chats with CRISPR Therapeutics' CEO. By Adam Feuerstein Opinion: Independent doctors like me are becoming an endangered species Cuts to Medicare reimbursement rates could drive yet more consolidation within the health care market. By Paul Berggreen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser